AS Indonesia sets its sights on becoming a thriving developed nation by 2045, one big question looms large: How do we safeguard our population from the “double burden” of deadly communicable and noncommunicable diseases (NCDs) that can threaten our productivity?
It is a valid concern since Indonesia is home to some of the highest incidences of tuberculosis (TB) and cardiovascular diseases in the world.
